BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025

  March 18, 2026

   · 

  12 min read
• Press Releases

  Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease

  March 18, 2026

   · 

  8 min read
• Press Releases

  Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR

  March 18, 2026

   · 

  7 min read
• Press Releases

  Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026

  March 18, 2026

   · 

  8 min read
• Press Releases

  SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

  March 18, 2026

   · 

  6 min read
• Press Releases

  CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

  March 18, 2026

   · 

  5 min read
• Press Releases

  Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report

  March 18, 2026

   · 

  17 min read
• Press Releases

  New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference

  March 18, 2026

   · 

  4 min read
• Press Releases

  Biovica International AB - Q3 Interim Report Nov 2025-Jan2026

  March 18, 2026

   · 

  6 min read
• Press Releases

  New AACR Data Expand Evidence for TKa In Immunotherapy-Treated Patients and CDK Inhibitor Dose Optimization

  March 18, 2026

   · 

  4 min read